Watts Guerra Law Firm Zantac Lawsuit: Everything You Need To Know In 2023
The year 2023 has seen a steady increase in the amount of legal action taken against the popular heartburn medication, Zantac. Watts Guerra Law Firm has been leading the charge in the numerous lawsuits filed against Sanofi, the manufacturer of Zantac, for its failure to warn consumers of the potentially harmful side effects of the drug. In this article, we will look at the intricate details of the Watts Guerra Law Firm Zantac lawsuit, and the various claims being made against Sanofi.
What is Zantac?
Zantac is a medication typically used to treat heartburn and acid reflux. It is a brand name for the drug ranitidine, which is an H2-receptor antagonist. H2-receptor antagonists are drugs that reduce the amount of acid produced in the stomach, thus relieving the symptoms of heartburn and acid reflux. It is a popular over-the-counter medication, and it has been available in the United States since 1983.
What is the Watts Guerra Law Firm Zantac Lawsuit About?
The lawsuit, filed in July of 2020, is claiming that Sanofi, the maker of Zantac, knew about the potential carcinogenic effects of the drug but failed to warn consumers of the danger. In particular, the lawsuit states that Sanofi has known since the 1980s that Zantac can contain NDMA, a known carcinogen, yet it has not taken any steps to alert consumers to the potential risks. The lawsuit also claims that Sanofi has known since the 1990s that the amount of NDMA in Zantac increases over time, yet it has still failed to take action.
What Types of Cancers Have Been Linked to Zantac?
The lawsuit filed by the Watts Guerra Law Firm states that Zantac has been linked to various types of cancers, including bladder cancer, stomach cancer, and esophageal cancer. The lawsuit also claims that Sanofi has known about the potential dangers of NDMA for decades, yet it has done nothing to warn consumers of the risks. As such, the lawsuit is seeking damages for those who have been diagnosed with cancer as a result of taking Zantac.
What Has Been Sanofi’s Response to the Lawsuit?
Sanofi has yet to respond to the lawsuit filed by the Watts Guerra Law Firm. However, the company has stated that it takes the safety of its customers very seriously and that it is working hard to ensure that all of its products are safe and effective. Additionally, Sanofi has recalled all of its Zantac products from the market, stating that it is aware of the potential risks posed by NDMA.
What is the Current Status of the Watts Guerra Law Firm Zantac Lawsuit?
The Watts Guerra Law Firm Zantac lawsuit is still ongoing. As of 2023, the lawsuit is currently in the discovery phase, where both sides are gathering evidence to support their claims. It is likely that the lawsuit will take several years to fully resolve. In the meantime, Sanofi will continue to face questions about its failure to alert consumers to the potential dangers of taking Zantac.
What Types of Damages Could Sanofi be Facing?
If the Watts Guerra Law Firm is successful in its lawsuit, Sanofi could potentially face millions of dollars in damages. This could include compensatory damages for medical expenses, lost wages, and pain and suffering, as well as punitive damages for Sanofi’s failure to warn consumers of the potential risks of taking Zantac. Additionally, there could also be a class-action lawsuit filed against Sanofi if the Watts Guerra Law Firm is successful in its case.
Where Can I Find More Information About the Watts Guerra Law Firm Zantac Lawsuit?
If you would like more information about the Watts Guerra Law Firm Zantac lawsuit, you can visit the firm’s website. Additionally, you can contact the firm directly if you or a loved one has been diagnosed with cancer after taking Zantac. Finally, you can also stay up to date with the latest news and developments in the case by following the firm on social media.
The Watts Guerra Law Firm Zantac lawsuit is an important case that has the potential to have a lasting impact on the pharmaceutical industry. The lawsuit is still in its early stages, and it is likely that it will take several years to resolve. In the meantime, Sanofi will face increasing scrutiny about its failure to warn consumers of the potential risks of taking Zantac.